Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

1.51
Delayed Data
As of 3:59pm ET
 +0.0338 / +2.28%
Today’s Change
0.86
Today|||52-Week Range
4.94
+16.45%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.48
Today’s open1.48
Day’s range1.45 - 1.57
Volume458,275
Average volume (3 months)517,346
Market cap$18.9M
Dividend yield--
Data as of 3:59pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+70.20%
Earnings growth (this year)+117.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.09%
P/E ratioNM
Price/Sales1.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...-0.00-0.30%
ACSTAcasti Pharma Inc+0.03+2.33%
TRPXTherapix Biosciences...+0.38+6.95%
KTOVKitov Pharmaceutical...-0.02-1.15%
Data as of 4:00pm ET, 08/23/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$5.8M
Annual profit (last year)-$7.4M
Net profit margin-128.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts